Universal Genetic Code Expansion Platform for Bacteria and Eukaryotes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genetic code expansion methods require separate platforms for bacteria and eukaryotes, limiting the ability to incorporate unnatural amino acids into proteins expressed in both cell types.

Innovation Solution

Development of a universal platform using the endogenous tryptophanyl-tRNA/tryptophanyl-tRNA synthetase pair in E. coli, which is functionally replaced with a yeast-derived counterpart, allowing for the directed evolution of orthogonal tRNA/aaRS pairs that can incorporate unnatural amino acids into both E. coli and eukaryotic cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If separate tRNA/aaRS platforms are used for bacteria and eukaryotes, then genetic code expansion can be achieved in each system, but the complexity of maintaining multiple platforms increases and the ability to use a single system for both cell types is limited

Engineering Contradiction:
Improveability to incorporate UAAs in both E. coli and eukaryotic cellsVSAvoidnumber of separate tRNA/aaRS platforms required
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The pyrrolysyl tRNA/PylRS pair from archaebacteria serves as a universal platform that functions in both bacterial and eukaryotic cells. This single orthogonal system can be used to incorporate unnatural amino acids into proteins expressed in either cell type, eliminating the need to maintain separate bacterial and eukaryotic platforms and enabling researchers to work with a unified system across different biological contexts.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of manufacture

If the E. coli based selection system is used for directed evolution, then the process is facile and successful for encoding new UAAs, but access to new active site topologies for structurally distinct UAAs is limited

Engineering Contradiction:
Improveease of directed evolution processVSAvoidaccess to new active site topologies for UAAs
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The pyrrolysyl tRNA/PylRS pair acts as an intermediary system that bridges the facile E. coli-based selection process with the ability to access diverse active site topologies. By using this universal orthogonal pair as the foundation, researchers can perform directed evolution in the easy-to-use E. coli system while still achieving access to a broader range of unnatural amino acid structures through the PylRS platform's versatility.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Device complexity

If endogenous tRNA/aaRS pairs are used, then the system is simple, but orthogonality with host counterparts is compromised leading to cross-reactivity

Engineering Contradiction:
Improvesimplicity of systemVSAvoidorthogonality and fidelity of translation
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The system segments the translation machinery into orthogonal components: the endogenous E. coli tRNA/aaRS system handles natural amino acids, while the imported pyrrolysyl tRNA/PylRS pair handles unnatural amino acids. This segmentation ensures that the two systems operate independently without cross-reactivity, maintaining both simplicity and reliability by keeping the pathways separate.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The pyrrolysyl tRNA/PylRS pair is extracted from archaebacteria and introduced into E. coli as a separate, orthogonal system. This extraction allows the E. coli host to maintain its native simple translation system while the imported pair provides dedicated functionality for unnatural amino acid incorporation without interfering with endogenous processes.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS12203115B2Universal platform for genetic code expansion
Publication Date: 2025.01.21 BOSTON COLLEGE
  • US12203115B2 patent drawing
  • US12203115B2 patent drawing
  • US12203115B2 patent drawing

AI summary

Methods and compositions are described for selecting and identifying orthogonal aminoacyl synthetase-tRNA pairs and their use to incorporate unnatural amino acids in a site-specific manner in proteins. Specifically described is a novel E. coli tyrptophanyl synthetase-tRNA pair that functions as both an opal and amber suppressor and that incorporates tryptophan analogs into proteins.